ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
The integration and transition of the brands are expected to be completed by June 2022.
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
A primary investment of Rs 194.4 crore has been made
TPE tubing from Freudenberg also offers many different sterilization options including autoclave, gamma irradiation, x-ray, and e-beam
Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
GenNext and Kiko Tech will provide sales and marketing, customer service, technical support, training, and related logistical efforts for Flash Oxidation Protein Footprinting Systems.
Subscribe To Our Newsletter & Stay Updated